Swiss National Bank - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 94 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,904,551
-19.1%
84,900
+1.1%
0.00%0.0%
Q2 2023$4,827,480
+54.4%
84,000
+0.7%
0.00%
+50.0%
Q1 2023$3,127,500
+18.0%
83,400
-11.8%
0.00%0.0%
Q4 2022$2,650,692
+1.9%
94,600
+2.2%
0.00%0.0%
Q3 2022$2,602,000
-17.3%
92,600
+2.3%
0.00%0.0%
Q2 2022$3,148,000
-3.1%
90,5000.0%0.00%0.0%
Q1 2022$3,249,000
+66.4%
90,500
+8.0%
0.00%
+100.0%
Q4 2021$1,952,000
+22.5%
83,8000.0%0.00%0.0%
Q3 2021$1,593,000
-5.7%
83,8000.0%0.00%0.0%
Q2 2021$1,689,000
+7.3%
83,800
-2.4%
0.00%0.0%
Q1 2021$1,574,000
-8.9%
85,9000.0%0.00%0.0%
Q4 2020$1,727,000
+9.8%
85,900
+2.4%
0.00%0.0%
Q3 2020$1,573,000
-16.5%
83,9000.0%0.00%
-50.0%
Q2 2020$1,884,000
+87.3%
83,900
+23.7%
0.00%
+100.0%
Q1 2020$1,006,000
-23.1%
67,8000.0%0.00%0.0%
Q4 2019$1,308,000
-0.4%
67,800
+2.4%
0.00%0.0%
Q3 2019$1,313,000
-3.4%
66,200
+2.8%
0.00%0.0%
Q2 2019$1,359,000
+5.6%
64,400
+2.2%
0.00%0.0%
Q1 2019$1,287,000
+4.8%
63,000
+2.1%
0.00%
-50.0%
Q4 2018$1,228,000
+3.5%
61,7000.0%0.00%
+100.0%
Q3 2018$1,187,000
+26.0%
61,7000.0%0.00%0.0%
Q2 2018$942,000
-24.3%
61,700
-7.1%
0.00%
-50.0%
Q1 2018$1,245,000
-2.6%
66,4000.0%0.00%
+100.0%
Q4 2017$1,278,000
+20.5%
66,400
+11.8%
0.00%0.0%
Q3 2017$1,061,0000.0%59,4000.0%0.00%0.0%
Q2 2017$1,061,000
+23.2%
59,4000.0%0.00%0.0%
Q1 2017$861,000
-17.1%
59,400
+5.3%
0.00%
-50.0%
Q4 2016$1,039,000
-2.9%
56,4000.0%0.00%0.0%
Q3 2016$1,070,000
+12.9%
56,400
-4.1%
0.00%0.0%
Q2 2016$948,000
+50.5%
58,800
+8.1%
0.00%
+100.0%
Q1 2016$630,000
+0.3%
54,400
+23.4%
0.00%
-50.0%
Q4 2015$628,000
+21.7%
44,1000.0%0.00%
+100.0%
Q3 2015$516,000
-23.6%
44,100
+14.8%
0.00%
-50.0%
Q2 2015$675,00038,4000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2016
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders